Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact

Chronic migraine (CM) is a neurological disease characterized by frequent migraine attacks that prevent affected individuals from performing daily activities of living, significantly diminish quality of life, and increase familial burden. Before onabotulinumtoxinA was approved for CM, there were few...

Descripción completa

Detalles Bibliográficos
Autores principales: Turkel, Catherine C., Aurora, Sheena, Diener, Hans-Christoph, Dodick, David W., Lipton, Richard B., Silberstein, Stephen D., Brin, Mitchell F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
OA Supplement Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374186/
https://www.ncbi.nlm.nih.gov/pubmed/37499085
http://dx.doi.org/10.1097/MD.0000000000032600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374186/
https://www.ncbi.nlm.nih.gov/pubmed/37499085
http://dx.doi.org/10.1097/MD.0000000000032600

Ejemplares similares